Recently, we evaluated uL3 clinical significance in colon cancer and demonstrated that uL3 expression in colon tumor tissues is downregulated; in particular, the decrease in uL3 mRNA levels associated with malignance progression and tumor grade and were inversely proportional to the ratio Bcl-2/Bax [15]. Here, RPL3 is linked to neoplasm.